Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Fondazione Policlinico Universitario Campus Bio-Medico clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Italy register with Fondazione Policlinico Universitario Campus Bio-Medico as lead sponsor. Synced 17 Nov 2026
17Current trials
13Recruiting now
2Drugs in these trials
1Trial register
At a glance

Fondazione Policlinico Universitario Campus Bio-Medico is the lead sponsor of 17 current clinical trials in our Italy register. 13 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Bacterial Lysate and Guselkumab. The most-studied condition is Shoulder Musculoskeletal Disorders.

ClinicalTrials.gov trials by status

  • Recruiting1376%
  • Not yet open16%
  • Active, closed16%
  • By invitation212%

Trials by phase

  • Not applicable1376%
  • Observational212%
  • Phase 4212%
01

Clinical trials sponsored by Fondazione Policlinico Universitario Campus Bio-Medico

17 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Dose Escalated Concomitant Boost Radiotherapy for Early Breast Cancer
NCT07021846 · ClinicalTrials.gov ↗ · Breast Cancer
Not applicable Recruiting 2020-03 Italy
Concomitant Radiotherapy and New Drugs in Metastatic Breast Cancer
NCT07021911 · ClinicalTrials.gov ↗ · Breast Cancer, Radiotherapy; Complications
Observational Recruiting 2023-05 Italy
Virtual Reality for Shoulder Rehabilitation
NCT06797492 · ClinicalTrials.gov ↗ · Shoulder Musculoskeletal Disorders
Not applicable Recruiting 2025-09 Italy
Identify the Most Effective Rehabilitation Method Between a Treatment with a Sensorized Treadmill (Walker View) and a Treatment with Conventional Group Therapy in Balance Disorders and the Use of Artificial Intelligence to Identify Predictive Indices to Prevent Falls and Diagnose Promptly the Risk
NCT06649500 · ClinicalTrials.gov ↗ · Balance Disorders, Rehabilitation, Falls
Not applicable Recruiting 2024-12 Italy
An Artificial Intelligence-based Approach in Total Knee Arthroplasty: From Inflammatory Responses to Personalized Medicine
NCT06634654 · ClinicalTrials.gov ↗ · Knee Osteoarthritis
Not applicable Recruiting 2024-10 Italy
Effects of a Telerehabilitation Intervention in the Management of Complications After Breast Cancer Surgery
NCT06608446 · ClinicalTrials.gov ↗ · Breast Neoplasms
Not applicable Recruiting 2023-05 Italy
Noninvasive Brain Stimulation for Cervical Dystonia
NCT07681284 · ClinicalTrials.gov ↗ · Cervical Dystonia
Not applicable Recruiting 2026-07 Italy
Soft Tissue Sarcoma: Motor Performance, Robotic Rehabilitation, Nutrition, and Quality of Life
NCT06873685 · ClinicalTrials.gov ↗ · Sarcoma, Soft Tissue
Not applicable Recruiting 2025-03 Italy
Potential Role of Guselkumab in Modulating PAIN Perception and Related Gene Pathways: a Proof-of-concept Study.
NCT06974474 · ClinicalTrials.gov ↗ · Psoriasis Arthritis
Phase 4 Recruiting 2024-06 Italy
Association of VAgus Nerve Stimulation and Treadmill Training for GAit Rehabilitation in DE Novo Parkinson's Disease
NCT07337226 · ClinicalTrials.gov ↗ · Idiopathic Parkinson's Disease (PD)
Not applicable Recruiting 2026-02 Italy
Biophotonic Nanoparticle-enabled Laser Blood Test for Early Detection of Pancreatic Cancer
NCT07659639 · Diabetes, IPMN, Pancreatic, PDAC - Pancreatic Ductal Adenocarcinoma
Not applicable Recruiting 2025-09 Italy
Low Impact Laparoscopy In Bariatric Surgery
NCT07119437 · ClinicalTrials.gov ↗ · Obesity, Morbid
Not applicable Recruiting 2025-02 Italy
Get-Ready App to Monitoring Obesity Patients Before and After Bariatric Surgery
NCT07839624 · ClinicalTrials.gov ↗ · Obesity
Not applicable Recruiting 2026-02 Italy
TL1A Inhibition in Systemic Sclerosis-Related Skin Fibrosis and Immunological Alterations: A Proof-of-Concept In Vitro Study (FIBROSTOP)
NCT07642297 · ClinicalTrials.gov ↗ · Systemic Sclerosis (SSc), Diffuse Cutaneous Systemic Sclerosis, Skin Fibrosis
Observational Not yet open 2026-09 Italy
Impact of Orthopedic Surgery on Workers' Sleep
NCT06854913 · ClinicalTrials.gov ↗ · Shoulder Musculoskeletal Disorders
Not applicable By invitation 2025-03 Italy
Passive Exoskeletons for Assisting Patients With Shoulder Musculoskeletal Disorders
NCT06842017 · ClinicalTrials.gov ↗ · Shoulder Musculoskeletal Disorders
Not applicable By invitation 2025-05 Italy
OM 85 to Prevent Respiratory Infections in Older At Risk Patients
NCT07178002 · ClinicalTrials.gov ↗ · Respiratory Tract Infections (RTI)
Phase 4 Active, closed 2024-12 Italy

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in Fondazione Policlinico Universitario Campus Bio-Medico trials

2 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in Fondazione Policlinico Universitario Campus Bio-Medico trials

22 conditions
Shoulder Musculoskeletal Disorders3Breast Cancer2Radiotherapy; Complications1Balance Disorders1Rehabilitation1Falls1Falls Prevention1Systemic Sclerosis (SSc)1Diffuse Cutaneous Systemic Sclerosis1Skin Fibrosis1Respiratory Tract Infections (RTI)1Knee Osteoarthritis1Breast Neoplasms1Cervical Dystonia1Sarcoma, Soft Tissue1Psoriasis Arthritis1Idiopathic Parkinson's Disease (PD)1Diabetes1IPMN, Pancreatic1PDAC - Pancreatic Ductal Adenocarcinoma1Obesity, Morbid1Obesity1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in Italy1713

A trial with sites in more than one country appears in each of those registers.

05

Questions about Fondazione Policlinico Universitario Campus Bio-Medico trials

How many clinical trials does Fondazione Policlinico Universitario Campus Bio-Medico sponsor?

Fondazione Policlinico Universitario Campus Bio-Medico is the lead sponsor of 17 current trials on ClinicalTrials.gov in our Italy register, as of the registry sync on 17 November 2026. Completed and withdrawn studies are not counted.

Are Fondazione Policlinico Universitario Campus Bio-Medico trials recruiting?

Yes. 13 of its 17 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Fondazione Policlinico Universitario Campus Bio-Medico testing?

Its current trials name 2 drugs and biologicals as interventions. The most frequent are Bacterial Lysate (1) and Guselkumab (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 17 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.